For the Inventor, By the Inventor

Enter assignee name

Risen (Suzhou) Pharma Tech Co., Ltd.

Calculating rank

USPTO Granted Patents = 16

Forward Citations = 14

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Jiasheng Lu (16 out of 20 patents)

Jiamin Gu (16 out of 19 patents)

Xianqi Kong (15 out of 42 patents)

4. Xiang Ji (11 out of 13 patents)

5. Daiqiang Hu (8 out of 9 patents)

6. Gang Chen (7 out of 9 patents)

7. Xinyong Lv (7 out of 8 patents)

8. Dongdong Wu (7 out of 10 patents)

9. Xiuchun Zhang (7 out of 8 patents)

10. Jinchao Ai (5 out of 6 patents)

11. Dongqing Zhu (5 out of 5 patents)

12. Xiaolin He (5 out of 5 patents)

13. Lin Wang (5 out of 33 patents)

14. Feng Zhou (4 out of 4 patents)

15. Guowei Song (3 out of 3 patents)

16 patents: Sort by Forward Citations

1. 12459888 - Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof (2025-11-04),

2. 12403129 - Isotope-enriched 3-amino-1-propanesulfonic acid derivatives for the treatment of cerebrovascular disease (2025-09-02),

3. 12365675 - Stable heavy isotopes in amide functional groups and uses thereof (2025-07-22),

4. 12338205 - Crystalline form of 3-((L-valyl) amino)-1-propanesulfonic acid (2025-06-24),

5. 12312378 - Glucosamine derivatives for the prevention or treatment of joint disorders (2025-05-27),

6. 11970490 - Stable heavy isotopes in amide functional groups and uses thereof (2024-04-30),

7. 11725020 - Prodrugs of a CDK inhibitor for treating cancers (2023-08-15),

8. 11718636 - Glucosamine derivatives for the prevention or treatment of joint disorders (2023-08-08),

9. 11608314 - Crystalline form of 3-((L-valyl) amino))-3, 3-dideuterium-1-propanesulfonic acid, preparation method and uses thereof (2023-03-21),

10. 11591358 - Glucosamine derivatives and pharmaceutical uses thereof (2023-02-28),

11. 11530234 - CD73 inhibitors and pharmaceutical uses thereof (2022-12-20),

12. 11225497 - Prodrugs of a CDK inhibitor for treating cancers (2022-01-18),

13. 11186543 - Crystalline form of 3-((L-valyl)amino))-3,3-dideuterium-1-propanesulfonic acid, preparation method and uses thereof (2021-11-30),

14. 10954188 - Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof (2021-03-23),

15. 10881681 - CD73 inhibitors and pharmaceutical uses thereof (2021-01-05),

Company Overview

Risen (Suzhou) Pharma Tech Co., Ltd. is a prominent player in the pharmaceutical and biotechnology sectors, specializing in the development and manufacturing of innovative drug delivery systems and formulations. The company focuses on enhancing therapeutic efficacy through advanced technologies, catering to a global market. With a strong emphasis on research and development, Risen is committed to addressing complex healthcare challenges and improving patient outcomes through its cutting-edge solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

16 Patents

#32 in Suzhou

#1,816 in China

#37,914 in the World

Risen (Suzhou) Pharma Tech Co., Ltd.

Forward Citations = 14

23 inventors:

Jiasheng Lu (16 out of 20 patents)

Jiamin Gu (16 out of 19 patents)

Xianqi Kong (15 out of 42 patents)

4. Xiang Ji (11 out of 13 patents)

5. Daiqiang Hu (8 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Risen (Suzhou) Pharma Tech Co., Ltd.. Retrieved from https://idiyas.com/company/risen-suzhou-pharma-tech-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…